Although not approved specifically for PCOS, GLP-1 RA use in women with PCOS has been associated with improved blood glucose control and weight loss, as well as improvements in menstrual regularity and a decrease in ovarian cysts ( 4 , 6 8 )
To overcome this assessment, pharmaceutical companies are instead targeting obesity-related co-morbidities, such as cardiovascular disease, chronic kidney disease and obstructive sleep apnoea, for which reimbursement is more likely
Follow Your Program Between Visits With the EZDietPlanner & Fitness Tracker app, you can follow the calorie specific meal plan and activities Dr
Gillian M
While BMI is an important starting point for eligibility, a comprehensive approach is taken, considering factors like existing medical conditions, medication interactions, dietary habits, physical activity levels, and individual health goals
Here are some others: Pancreatitis Pancreatitis is the inflammation or swelling of the pancreas and can, on rare occasions, potentially be triggered by GLP-1 drugs like Ozempic
